Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dr. Moro, if you are really interested in treating cancer, please take some of the money you have stolen and make a charitable contribution to a truly worthy cause fighting it.
Might I suggest the American Cancer Society.
Happy Holidays.
You may be correct. No investor is stupid enough to pay 25 cents a share but what is does is raise the average so that Asher cannot sell shares and make money.
I bet that Moro is buying the shares at 0.25. Manipulation is his way. For a company with no value at all, what other explanation is out there?
Has anyone figured out why BOCXD is not trading? A quote shows a bid of 5 cents but no ask at all. Are the brokers not allowing the current holders of shares to sell?
then why don't you tell them?
It is clearly illegal and you can be sure that Moro did not tell FINRA that the shareholder vote had expired.
if it were illegal then how could it be moving forward?
This reverse split is clearly illegal. The shareholder approval expired on Nov 30.
Smithline will probably foreclose during Jan 2013 taking any all assets.
13:04 12/17/2012 BOCX BioCurex, Inc. Common Stock BOCXD BioCurex, Inc. NEW Common Stock 1-150 R/S **
http://otcbb.com/asp/dailylist_detail.asp?d=12/14/2012&mkt_ctg=ALL
I_Invest, that could possibly solve the universal aspect but it does nothing to solve the false positive aspect of the test. Moro even admits in the web page on Dog RECAF that falses exist. His solution was to raise the cutoff level for a positive test but that would cause the accuracy of the test to miss about 50 of the cancers.
The false positve rate is just way too high for this test to be used for screening and that is where the big money is.
There is some promising research in shutting off the mechanism in cancer that wards of T-cells from attacking cancer as a foreign body.
If scientists can stop that mechanism in cancer then they can get the body to attack cancer.
If this is the solution then it really doesn't matter what kind of cancer it is and where it's located.
This would give BioCurex's broad test an avenue.
However, given the poor Management and what really looks like a giant fraud against shareholders I am betting this ship goes down and Moro starts a secondary company to start the fraud all over again.
Since Moro has shifted his fiscal year reporting in an attempt to save some auditor fees. He is a fool....
The SEC requires a 10K transition report to be made that covers the transition period also but the corp is also required to file an audited 10K for the previous fiscal year. NO REPORTING PERIOD CAN EXCEED 12 MONTHS.
Moro just created MORE expense for the company.
Moro: read section 1360:
http://www.sec.gov/divisions/corpfin/cffinancialreportingmanual.pdf
I_Invest, I don't think RECAF ever had the potential to be an accepted product once the number of false positives were exposed. regardless of anyones business ability, RECAF would never have succeeded. Add to that Moro's constant attempts to scam people, it really was a bad investment. The key was the limited ability to do proper DD. 99% of any information was coming from Moro and most thought a medical doctor would not be running a scam.
i've said it before and I'll say it again...
If I ever see Dr. Moro walking down the street I am going to punch him in the face. He's about as good at business as George W. Bush.
I_Invest, someone needs to post what Moro is up to and I have taken on the task. If only one person looks at this board, that is fine with me and I know Moro reads the board. I love exposing his tricks and scams.
What do you think about Moro pocketing all that SR&ED money? I think that is the same as theft. That money rightfully belongs to BioCurex and all he has to do is to not charge BioCurex for future R&D but he will never do that. It is all about scam and money for him.
hey gold...who are you talking to?
as far as i can tell....there's no one even here any more.
I don't think FINRA is going to approve the reverse stock split. It has now been two months and no announcement.
No reverse stock split and Moro runs out of shares to pay off Asher and may run out even before April 2013.
If Smithline thinks he can get enough assets to pay off his debt of $540,000 at the end of December, he will foreclose. If there is no money be be had, then it would do him no good to foreclose except to sell the shell. IMO, Smithline is a wildcard and not sure what direction he will take.
If you could let me know when they are the end of the road that's when I will have to sell, t
he price does
n't have to go far and I am even.
Skipper, Good luck in getting your money back. I think Moro intends to ignore the shareholder authorization expiring and is hoping that FINRA will finally approve the split. It has now been over two months so if FINRA approves it at this point, it would be a shock.
Moro has gotten away with a lot of lies because of his claim of a medical degree. Investors assume a doctor would have high ethics.
I'm trying just to break even not expecting anything more.
Moro has also apparently changed his fiscal year so he would not have to file a 10k at the end of this year. I'm sure he hopes to save/delay the auditor fees that would have to come directly out of his pocket since BioCurex is out of money.
It is just one scam after another.
" If the reverse stock split is adopted by the stockholders but is not implemented by November 30, 2012, this proposal will be deemed abandoned. "
It is obvious from the above in the DEF14, that any split at this point would be illegal.
Moro has filed an 8K about the reverse split. It would appear that his pleading to FINRA has got them to approve the split. He will probably claim that the shareholder authorization did not expire on 30 November.
Asher sold 5.1 million shares today. With both Asher and employee selling, the number of available shares is dropping rapidly.
It is ironic how many times Moro has suggested that investors sue me for my postings when in fact investors should be suing Moro for his theft of SR&ED money he has been pocketing above and beyond the money BioCurex has paid him.
One thing certain about FINRA denying the reverse split. It will stop Moro from continuing to scam money from investors.
I expect him to continue in business at least through the end of 2012 so he can bill BioCurex for the R&D performed by Pacific BioSciences. He can then submit another claim to rebate the R&D for 2012 with the Canadian Tax Authority for more SR&ED money to line his pockets.
It is all about scam here. He will default on the Smithline loan in 29 more days. He cannot get any more money from Asher but if Smithline does not foreclose, Moro could continue to claim R&D to bill BioCurex. Even though Biocurex cannot pay, Moro would submit the amount to the CRA to get more SR&ED money for 2013.
The shareholders are certainly the big losers in BioCurex. Moro has always pockedt his salary and profit from Pacific BioSciences, his private company doing all of the work for BioCurex.
Moro has also been pocketing ALL of the Canadian Tax Authority SR&ED money which has probably totaled over $1.5 million. He has done well in this scam.
IMO, he will just shut down Pacific BioSciences and probably return to South America although, he may attempt to come up with another scam.
New all time low this morning of $.0004.
It is all over now.
Moro and BioCurex are finished. FINRA has just allowed the reverse split to expire. FINRA has seen through the scam Moro was running. They obviously did not like the severity of the proposed reverse split and they MOST undoubtedly did not like the fact that Moro scammed the shareholder vote with buying 80 million shares, voting for the proxy and then selling them back to the company a month later.
Moro's scams have finally done him in. I guess that proves Moro is not as smart as he thinks he is.
There is no way that Moro can now raise money to pay for staying in business. He owes Asher another $42,500 and he owes Smithline $540,000 that is due in one month. Moro only has another 130 million or so shares left and at $.0005, that would only add up to $65,000.
Tomorrow is the last day for FINRA to effect a reverse split.
It is now down to two days for FINRA to effect the reverse split before the shareholder authorization expires.
IMO, Moro severely underestimated the powers of FINRA and submitted his application to reverse split way too late.
It is now down to 3 days for FINRA to effect the reverse split and change the ticker symbol to BOCXD.
It looks like FINRA is going to just let the application die.
Sill no indication of FINRA approval. The clock is ticking.
It may very well be that FINRA will just let the time limit expire without making a ruling.
Moro is no doubt "fit to be tied".
4 more days to obtain FINRA approval for the reverse split or the shareholder authorization expires.
Not many days left to obtain FINRA approval for the reverse split. The shareholder vote expires at the end of November.
"If the reverse stock split is adopted by the stockholders but is
not implemented by November 30, 2012, this proposal will be deemed abandoned."
A delay by FINRA past November 30 could be a method FINRA uses to deny the split without making any adverse decision.
Dog RECAF is obviously a failed product. Instead of an increase in sales each quarter, the company is reporting a decrease in sales. If sales for dogs is bad, IMO, any sales for Cat RECAF would be horrible.
BioCurex now has no product that will provide sufficient revenue for survival. The company is now surviving by getting convertible loans on death spiral terms.
The only prospect BioCurex has is more massive dilution.
Moro finally files a US patent application for the synthetic peptide.
http://www.freshpatents.com/Ralph-H-Schmid-Vancouver-invdirs.php
Reverse stock split NOT YET APPROVED BY FINRA.
"The reverse split will become effective on the OTC Bulletin Board when FINRA has approved the Company's documentation pertaining to the stock split."
FINRA is certainly dragging their feet on approving the reverse split. It has now been over a month since Moro made the application to FINRA. The reverse split has to be effected by the end of November or the authorization by the shareholders is void.
IMO, it may be highly likely FINRA will delay any approval until the authorization period has expired. That way, FINRA does not have to deny the reverse split, it just dies on its own.
12 more business days left to obtain approval.
Moro takes another death spiral note from Asher.
"In October 2012, the Company issued a convertible note with a principal amount of $42,500, to a private investor."
"The conversion price is 58% of the average of the lowest three Trading Prices for the Company’s common stock during the ten trading day period ending on the trading day prior to the date the note is converted"
Quarterly revenue dropped again.
Dog RECAF sales have now dropped to $7,933 for the 3rd quarter.
I did not want to reply on the other board--tried to "buy" right before the close via TDA--still did not trade.
BOCX - Thanks for the cheapies. :)
Seann, Asher is not the only negative thing about this company
1. Dog RECAF is NOT selling well at all. Meager revenues and it dropped 40% in the last quarter to $6,000.
2. Work on human products has ceased. Moro has mentioned the next product as Cat RECAF which wont sell either.
3. Moro has laid off almost all of his employees at his private firm which does all the contract work for BioCurex a ripoff rates.
4. Moro is personally pocketing all of the research rebate money from the Canadian Revenue Authority. That adds up to over $1.5 million in the past two years.
5. BioCurex is broke. Cash is limited to what he can borrow from Asher and pay back in shares discounted 58% to current share price.
6. BioCurex owes about $550,000 to hedge funds run by Richard Smithline due in December. There is no way he can pay it.
7. Moro has scammed the past two shareholder meeting votes by exercising options, voting and then unexercising the options. In the last vote, he bought 80 million shares and after voting, sold them back to Biocurex.
8. BioCurex China is a scam with no employees.
Asher sold 3.8 million shares today. At this share price, the $31,000 note converts into 76.3 million shares.
Not only is Moro scamming the proxy votes, he is pocketing the Canadian SR&ED money instead of reducing his charges by his personally owned company, Pacific BioSciences.
Moro has put about $1.5 million in his pocket from Rebates by the SR&ED program.
Moro is totally silent about pocketing all this money.
It has been 26 days since Moro filed the 8K announcing a reverse split. What happened? Has FINRA not approved it?
Since Moro sold his 80 million shares back to BioCurex, there are 308,655,000 outstanding shares.
What a scam. Back in 2009, Moro exercised a TON of options and voted them in the shareholder proxy. He then UNEXERCISED them.
In July 2012, Moro bought 80 million shares with debt to Pacific BioSciences. He voted on the proxy. He then sold the shares back to BioCurex for debt.
This company is a TOTAL SCAM.
Moro tells more lies.
From the 8K filed on Oct 12, 2012:
" The reverse split will become effective on the OTC Bulletin Board when FINRA has approved the Company's documentation pertaining to the stock split."
BioCurex is on the PINK SHEETS.
"BioCurex Inc. Deleted From OTCBB
Jul 23 12
BioCurex Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 23, 2012 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11."
http://investing.businessweek.com/research/stocks/snapshot/snapshot.asp?ticker=BOCX
Interesting News...
http://www.internationalhifu.com/
Video
BioCurex Inc. Deleted From OTCBB
Jul 23 12
BioCurex Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 23, 2012 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.
Followers
|
80
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
30387
|
Created
|
04/11/04
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |